Research

Run sleep studies at home, at any scale.

Wesper helps investigators and partners run sleep and cardiometabolic studies with a home-first workflow, multi-night data and managed participant logistics.

  • SOC 2 Type 2 and HIPAA
  • Multi-Night Data
  • Managed Participant Logistics
A researcher reviewing a Wesper sleep report

Who It's For

Who we work with.

Universities and research institutes

Observational studies, validation work, longitudinal cohorts and outcomes research, without shipping headaches.

Sleep programs and care networks

Standardize home testing across sites with one workflow and one data format.

Industry and innovation partners

Pilots and evidence generation with consistent devices, support and data outputs.

Illustrative sleep architecture across four nights
Illustrative AHI by sleep stage

What You Can Study

Multi-night data from real-world settings.

Wesper's FDA-cleared signals, multi-night testing and longitudinal record make home studies practical at scale.

  • Multi-night sleep phenotypes and night-to-night variability
  • Screening and follow-on diagnostic pathways
  • Cardiometabolic comorbidity cohorts, such as hypertension, obesity and diabetes
  • Treatment response and longitudinal monitoring
  • Real-world evidence and workflow outcomes

Why Wesper

We handle the study logistics.

Participant logistics

Dropship, instructions, reminders and returns, managed for your cohort.

Longitudinal by design

Repeat studies on one record, with 45+ trends tracked per participant.

Secure data

SOC 2 Type 2 and HIPAA compliant, with data delivery configured to your endpoints.

Evidence

What the data shows.

Wesper has been studied against in-lab polysomnography and against clinicians' own scoring. The source for each result is listed with it.

95%+

AHI correlation to in-lab PSG

Sleep Medicine 2025; JCSM 2023

r = 0.98

Automatic scoring vs. provider manual scoring

Sleep Medicine 2026

<5 days

From order to successful test

Wesper, Q3 2026

99%+

Patient success rate

Wesper, Q3 2026

TIME Best Inventions of 2026, Special Mention. Read the announcement

Clinical Validation

Peer-reviewed and presented.

Wesper Device Grant

Device support for high-impact studies.

If your team is advancing sleep science, care access or cardiometabolic research, you may qualify for device support.